more_reports

The Latest Life Sciences Tools & Diagnostics Articles from Streetwise Reports

Centrally Positioned AI Co. Platform Designed To Transform Healthcare

Contributed Opinion
  ()
Technical Analyst Clive Maund explains why he thinks now is an excellent time to buy or add to positions in Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA).

Biopharma Company Leverages AI-Powered Platform for Cancer Breakthroughs

  ()
Rakovina Therapeutics Inc. (RKV:TSX.V) announced its scientific advisor and collaborator Dr. Artem Cherkasov was recently recognized as a leader in AI-driven drug development. Find out which analysts recently initiated coverage on the company.

Two Use Cases for AI in Healthcare

  ()
In both, proprietary software platforms analyze heaps of data, but one focuses on genetics, the other neurology. Learn more about the companies behind the technology.

AI Stock in an Uptrend That Is Likely To Continue

Contributed Opinion
  ()
Technical Analyst Clive Maund explains why he thinks Light AI Inc. (ALGO:CBOE) is an Immediate Strong Buy.

Tech Innovator Achieves Breakthrough Multi-Market Success

  ()
Clean technology company BioLargo Inc. (BLGO:OTCQX) announces it had a "widely successful" and "transformative" 2024 and is looking forward to more revenue growth in 2025. Read why one expert thinks investors should be doubling down on the stock.

AI Company Unlocks Breakthrough Medical Diagnostics Platform

  ()
One company being listed on Cboe Canada starting January 8 is using AI and smartphones to help patients get quick and accurate diagnosis of their sore throats, helping to battle microbial resistance that threatens the effectiveness of antibiotics worldwide.

Is This Centrally Positioned AI Healthcare Co. Set to Transform the Industry?

Contributed Opinion
  ()
Technical Analyst Clive Maund explains why he thinks Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) offers potential upside to investors.

AI Accelerates Breakthroughs in Cancer Drug Discovery

  ()
Rakovina Therapeutics Inc. (RKV:TSX.V) is advancing cancer drug discovery with its Deep Docking AI platform. Read more about their recent developments and future plans.

Showing Results: 1 to 8 of 8